カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界のJE不活化ワクチン市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global JE Inactivated Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7897）・商品コード：GIR23SM7897
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のJE不活化ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のJE不活化ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- JE不活化ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

JE不活化ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・ハムスター腎細胞、ベロ細胞

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Bharat Biotech、Biological E. Limited、Biken、Seqirus、Liaoning Chengda、Valneva Austria GmbH

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、JE不活化ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なJE不活化ワクチンメーカーの企業概要、2019年～2022年までのJE不活化ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なJE不活化ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別JE不活化ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのJE不活化ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのJE不活化ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびJE不活化ワクチンの産業チェーンを掲載しています。
・第14、15章では、JE不活化ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– JE不活化ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：ハムスター腎細胞、ベロ細胞
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界のJE不活化ワクチン市場規模・予測
– 世界のJE不活化ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bharat Biotech、Biological E. Limited、Biken、Seqirus、Liaoning Chengda、Valneva Austria GmbH
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：ハムスター腎細胞、ベロ細胞
・用途別分析2018年-2029年：病院、診療所
・JE不活化ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・JE不活化ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・JE不活化ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・JE不活化ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・JE不活化ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of JE Inactivated Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global JE Inactivated Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Hamster Kidney Cells
1.3.3 Vero Cells
1.4 Market Analysis by Application
1.4.1 Overview: Global JE Inactivated Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global JE Inactivated Vaccine Market Size & Forecast
1.5.1 Global JE Inactivated Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global JE Inactivated Vaccine Sales Quantity (2018-2029)
1.5.3 Global JE Inactivated Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech JE Inactivated Vaccine Product and Services
2.1.4 Bharat Biotech JE Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Biological E. Limited
2.2.1 Biological E. Limited Details
2.2.2 Biological E. Limited Major Business
2.2.3 Biological E. Limited JE Inactivated Vaccine Product and Services
2.2.4 Biological E. Limited JE Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biological E. Limited Recent Developments/Updates
2.3 Biken
2.3.1 Biken Details
2.3.2 Biken Major Business
2.3.3 Biken JE Inactivated Vaccine Product and Services
2.3.4 Biken JE Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biken Recent Developments/Updates
2.4 Seqirus
2.4.1 Seqirus Details
2.4.2 Seqirus Major Business
2.4.3 Seqirus JE Inactivated Vaccine Product and Services
2.4.4 Seqirus JE Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Seqirus Recent Developments/Updates
2.5 Liaoning Chengda
2.5.1 Liaoning Chengda Details
2.5.2 Liaoning Chengda Major Business
2.5.3 Liaoning Chengda JE Inactivated Vaccine Product and Services
2.5.4 Liaoning Chengda JE Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Liaoning Chengda Recent Developments/Updates
2.6 Valneva Austria GmbH
2.6.1 Valneva Austria GmbH Details
2.6.2 Valneva Austria GmbH Major Business
2.6.3 Valneva Austria GmbH JE Inactivated Vaccine Product and Services
2.6.4 Valneva Austria GmbH JE Inactivated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Valneva Austria GmbH Recent Developments/Updates
3 Competitive Environment: JE Inactivated Vaccine by Manufacturer
3.1 Global JE Inactivated Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global JE Inactivated Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global JE Inactivated Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of JE Inactivated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 JE Inactivated Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 JE Inactivated Vaccine Manufacturer Market Share in 2022
3.5 JE Inactivated Vaccine Market: Overall Company Footprint Analysis
3.5.1 JE Inactivated Vaccine Market: Region Footprint
3.5.2 JE Inactivated Vaccine Market: Company Product Type Footprint
3.5.3 JE Inactivated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global JE Inactivated Vaccine Market Size by Region
4.1.1 Global JE Inactivated Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global JE Inactivated Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global JE Inactivated Vaccine Average Price by Region (2018-2029)
4.2 North America JE Inactivated Vaccine Consumption Value (2018-2029)
4.3 Europe JE Inactivated Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific JE Inactivated Vaccine Consumption Value (2018-2029)
4.5 South America JE Inactivated Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa JE Inactivated Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global JE Inactivated Vaccine Sales Quantity by Type (2018-2029)
5.2 Global JE Inactivated Vaccine Consumption Value by Type (2018-2029)
5.3 Global JE Inactivated Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global JE Inactivated Vaccine Sales Quantity by Application (2018-2029)
6.2 Global JE Inactivated Vaccine Consumption Value by Application (2018-2029)
6.3 Global JE Inactivated Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America JE Inactivated Vaccine Sales Quantity by Type (2018-2029)
7.2 North America JE Inactivated Vaccine Sales Quantity by Application (2018-2029)
7.3 North America JE Inactivated Vaccine Market Size by Country
7.3.1 North America JE Inactivated Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America JE Inactivated Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe JE Inactivated Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe JE Inactivated Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe JE Inactivated Vaccine Market Size by Country
8.3.1 Europe JE Inactivated Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe JE Inactivated Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific JE Inactivated Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific JE Inactivated Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific JE Inactivated Vaccine Market Size by Region
9.3.1 Asia-Pacific JE Inactivated Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific JE Inactivated Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America JE Inactivated Vaccine Sales Quantity by Type (2018-2029)
10.2 South America JE Inactivated Vaccine Sales Quantity by Application (2018-2029)
10.3 South America JE Inactivated Vaccine Market Size by Country
10.3.1 South America JE Inactivated Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America JE Inactivated Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa JE Inactivated Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa JE Inactivated Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa JE Inactivated Vaccine Market Size by Country
11.3.1 Middle East & Africa JE Inactivated Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa JE Inactivated Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 JE Inactivated Vaccine Market Drivers
12.2 JE Inactivated Vaccine Market Restraints
12.3 JE Inactivated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of JE Inactivated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of JE Inactivated Vaccine
13.3 JE Inactivated Vaccine Production Process
13.4 JE Inactivated Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 JE Inactivated Vaccine Typical Distributors
14.3 JE Inactivated Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global JE Inactivated Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global JE Inactivated Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech JE Inactivated Vaccine Product and Services
Table 6. Bharat Biotech JE Inactivated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Biological E. Limited Basic Information, Manufacturing Base and Competitors
Table 9. Biological E. Limited Major Business
Table 10. Biological E. Limited JE Inactivated Vaccine Product and Services
Table 11. Biological E. Limited JE Inactivated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Biological E. Limited Recent Developments/Updates
Table 13. Biken Basic Information, Manufacturing Base and Competitors
Table 14. Biken Major Business
Table 15. Biken JE Inactivated Vaccine Product and Services
Table 16. Biken JE Inactivated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Biken Recent Developments/Updates
Table 18. Seqirus Basic Information, Manufacturing Base and Competitors
Table 19. Seqirus Major Business
Table 20. Seqirus JE Inactivated Vaccine Product and Services
Table 21. Seqirus JE Inactivated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Seqirus Recent Developments/Updates
Table 23. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 24. Liaoning Chengda Major Business
Table 25. Liaoning Chengda JE Inactivated Vaccine Product and Services
Table 26. Liaoning Chengda JE Inactivated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Liaoning Chengda Recent Developments/Updates
Table 28. Valneva Austria GmbH Basic Information, Manufacturing Base and Competitors
Table 29. Valneva Austria GmbH Major Business
Table 30. Valneva Austria GmbH JE Inactivated Vaccine Product and Services
Table 31. Valneva Austria GmbH JE Inactivated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Valneva Austria GmbH Recent Developments/Updates
Table 33. Global JE Inactivated Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global JE Inactivated Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global JE Inactivated Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in JE Inactivated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and JE Inactivated Vaccine Production Site of Key Manufacturer
Table 38. JE Inactivated Vaccine Market: Company Product Type Footprint
Table 39. JE Inactivated Vaccine Market: Company Product Application Footprint
Table 40. JE Inactivated Vaccine New Market Entrants and Barriers to Market Entry
Table 41. JE Inactivated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global JE Inactivated Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global JE Inactivated Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global JE Inactivated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global JE Inactivated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global JE Inactivated Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global JE Inactivated Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global JE Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global JE Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global JE Inactivated Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global JE Inactivated Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global JE Inactivated Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global JE Inactivated Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global JE Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global JE Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global JE Inactivated Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global JE Inactivated Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global JE Inactivated Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global JE Inactivated Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America JE Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America JE Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America JE Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America JE Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America JE Inactivated Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America JE Inactivated Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America JE Inactivated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America JE Inactivated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe JE Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe JE Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe JE Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe JE Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe JE Inactivated Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe JE Inactivated Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe JE Inactivated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe JE Inactivated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific JE Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific JE Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific JE Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific JE Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific JE Inactivated Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific JE Inactivated Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific JE Inactivated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific JE Inactivated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America JE Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America JE Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America JE Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America JE Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America JE Inactivated Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America JE Inactivated Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America JE Inactivated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America JE Inactivated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa JE Inactivated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa JE Inactivated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa JE Inactivated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa JE Inactivated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa JE Inactivated Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa JE Inactivated Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa JE Inactivated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa JE Inactivated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 100. JE Inactivated Vaccine Raw Material
Table 101. Key Manufacturers of JE Inactivated Vaccine Raw Materials
Table 102. JE Inactivated Vaccine Typical Distributors
Table 103. JE Inactivated Vaccine Typical Customers
List of Figures
Figure 1. JE Inactivated Vaccine Picture
Figure 2. Global JE Inactivated Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global JE Inactivated Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Hamster Kidney Cells Examples
Figure 5. Vero Cells Examples
Figure 6. Global JE Inactivated Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global JE Inactivated Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global JE Inactivated Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global JE Inactivated Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global JE Inactivated Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global JE Inactivated Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global JE Inactivated Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global JE Inactivated Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of JE Inactivated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 JE Inactivated Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 JE Inactivated Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global JE Inactivated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global JE Inactivated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America JE Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe JE Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific JE Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America JE Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa JE Inactivated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global JE Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global JE Inactivated Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global JE Inactivated Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global JE Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global JE Inactivated Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global JE Inactivated Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America JE Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America JE Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America JE Inactivated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America JE Inactivated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe JE Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe JE Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe JE Inactivated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe JE Inactivated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific JE Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific JE Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific JE Inactivated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific JE Inactivated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America JE Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America JE Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America JE Inactivated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America JE Inactivated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa JE Inactivated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa JE Inactivated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa JE Inactivated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa JE Inactivated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa JE Inactivated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. JE Inactivated Vaccine Market Drivers
Figure 73. JE Inactivated Vaccine Market Restraints
Figure 74. JE Inactivated Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of JE Inactivated Vaccine in 2022
Figure 77. Manufacturing Process Analysis of JE Inactivated Vaccine
Figure 78. JE Inactivated Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


★調査レポート[世界のJE不活化ワクチン市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7897)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のJE不活化ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヘモフィルス・パラスイス二価ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のmRNA新型コロナウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のHPV四価ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口コレラワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の豚用弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の牛疫ウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の新型コロナウイルス感染用症経口ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の豚連鎖球菌ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経鼻ワクチン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆